Skip to main content
← All data ties

Cancer Treatment Research in California 31st District (CA-31)

USAspending.gov records $429,829,264.88 in Cancer Treatment Research (CFDA 93.395) obligations with place of performance in California 31st District (CA-31), across 36 awards. Thirty-six cancer-treatment rows against a $429,829,264.88 book is a research file, not thirty-six trials. The pair is about 12.8% of the district’s $3,355,783,586.90 all-program obligation total in this extract. The dollars are obligations, not outlays.

Key figures

  • Cancer Treatment Research in California 31st District (CA-31): $429,829,264.88 across 36 awards.
  • About 12.8% of the district’s $3,355,783,586.90 all-program obligation total.
  • Average obligation per award is about $11,939,701.80 (ratio only).
  • The join is CFDA 93.395 × California 31st District (CA-31) place of performance, not a cancer-incidence ranking or a hospital oncology budget.
  • Figures are USAspending obligations, not outlays.

CA-31 × 93.395 is an NCI join, not an incidence ranking

Cancer Treatment Research meets California 31st District (CA-31) on this page. $429,829,264.88 is the obligation sum on awards that carry both the CFDA 93.395 tag and congressional-district place of performance CA-31. It is not California’s statewide Cancer Treatment Research book, not the nationwide program total, and not a cancer-incidence ranking or a hospital oncology budget. California 31st District is the district parent without this program filter. CFDA 93.395 is the program parent without the CA-31 filter. Correlation is not causation.

36 is an award-action count. Modifications can add rows. Unique recipients are unpublished, and this page will not invent contractors or award recipients. Dividing $429,829,264.88 by 36 yields about $11,939,701.80 per award, a ratio of two packet facts, not a typical R01 or a typical protocol year. FEC contribution tables do not fund these USAspending obligations. Cancer Treatment Research is an NCI catalog line. Valley folklore is not a named-recipient list.

Cancer Treatment Research without a protocol inventory

The official catalog title is CANCER TREATMENT RESEARCH. SpendingVault does not grade California 31st District (CA-31) on Cancer Treatment Research, backlog, or policy. $429,829,264.88 is an obligation sum, not a verdict. CFDA 93.395 without the district filter is the national hub; this packet has no national total, so none is quoted. Other NCI or NIH institute listings remain outside $429,829,264.88.

NIH RePORTER, NCI program announcements, and clinical-trial registries are other series. They are not the 36 awards on USAspending.gov. Mixing a census from those files with this join would invent a per-unit dollar figure the packet does not support. NCI-protocol and medical-center folklore is ordinary speech, not a packet field. This packet has no trial registry. The PA-03 cancer-treatment cell in this slice is a different district stamp.

California 31st District besides CFDA 93.395

California 31st District (CA-31) is the geography side. Place of performance CA-31 is a coding field in the award file. It does not prove residency of beneficiaries, students, patients, or vendors. California federal spending is the statewide parent and includes other districts. San Gabriel Valley speech is not a census-tract split. Neighboring CA-28 NCI cells stay outside. A Cancer Treatment Research award tagged to CA-28 or CA-35 is not here.

The district’s all-program obligation total is $3,355,783,586.90. $429,829,264.88 is the Cancer Treatment Research slice of that book, about 12.8%. Remaining district dollars sit with other CFDAs on California 31st District, not inside this join. Quoting $429,829,264.88 as California 31st District (CA-31)’s entire federal book would drop every other catalog line.

Thirty-six awards, not 36 investigators

36 awards against $429,829,264.88 implies about $11,939,701.80 per award. That mean is not a unit price and not a typical R01 or a typical protocol year. Research project awards and competing continuations can dominate dollars while the row count stays at 36. 36 rows can include continuations and amendments. Treat the count as records in an aggregate, not as 36 finished projects or 36 people. All spending ties lists other district-by-program pairs on the same obligation metric.

NCI obligations versus invoices already paid

An obligation is a recorded commitment. An outlay is a payment from the Treasury. $429,829,264.88 is the commitment figure. This packet has no outlay total and no fiscal-year split, so none is invented. Citing the figure as cash already spent in California 31st District (CA-31) over-reads the field. Do not rank California 31st District (CA-31) as a winner or loser versus other districts. Keep both sides in the citation: Cancer Treatment Research (CFDA 93.395) and California 31st District (CA-31).

Budget documents from the San Gabriel Valley communities in the district and California appropriations answer other questions. They are not the source of this cell. If a chart mixes General Fund activity with CFDA 93.395 in CA-31, the chart has left the federal award series. The eastern Los Angeles basin as speech only did not receive $429,829,264.88 as a named metro in this packet.

How to cite the 93.395 × CA-31 pair

Cite: Cancer Treatment Research (CFDA 93.395) obligated $429,829,264.88 on 36 awards coded to California 31st District (CA-31), per USAspending.gov. Keep both keys. Keep the word obligations. Open California 31st District for the district rollup, CFDA 93.395 for the program rollup, California federal spending for California statewide spending, and All spending ties for other pairs. Later bulk files can move the dollars and the 36-award count; prefer those tables when the live overlay and this snapshot diverge. None of those links convert this cell into a cancer-incidence ranking or a hospital oncology budget, into outlays this packet omits, or into a contractor list.

Questions

How much Cancer Treatment Research funding is obligated in California 31st District (CA-31)?
USAspending.gov records $429,829,264.88 in CFDA 93.395 obligations with California 31st District (CA-31) place of performance across 36 awards. That is a program × district join, not an outlay and not California’s full federal total.
Do 36 awards mean 36 local trial, lab,s?
No. 36 is an award-action count and can include modifications. Unique recipients are unpublished. Average obligation is about $11,939,701.80 per award, a ratio of two packet facts, not a typical R01 or a typical protocol year.
Is this California 31st District (CA-31)’s entire federal spending total?
No. $429,829,264.88 is only the Cancer Treatment Research slice tagged to California 31st District (CA-31), about 12.8% of the district’s $3,355,783,586.90 all-program total. California federal spending is the statewide parent. Other CFDAs on California 31st District sit outside this join.
Where are the live CA-31 and CFDA 93.395 tables?
California 31st District is the district parent. CFDA 93.395 is the CFDA 93.395 hub. California federal spending is the California parent. All spending ties lists other pairs. Prefer those tables after later ingests; this page quotes 93.395 × CA-31 at $429,829,264.88.

USAspending.gov congressional district place-of-performance joined to CFDA program. Obligations are not outlays.